Change in the hepatic profile of hepatitis C virus genotype 4–infected patients with compensated cirrhosis receiving ombitasvir, paritaprevir, and ritonavir plus ribavirin: A subanalysis of the AGATE‐II study-Reference-Cited by-同舟云学术

Change in the hepatic profile of hepatitis C virus genotype 4–infected patients with compensated cirrhosis receiving ombitasvir, paritaprevir, and ritonavir plus ribavirin: A subanalysis of the AGATE‐II study

Published:2018-07-16 Issue:11 Volume:90 Page:1739-1744
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:J Med Virol

Author:

Waked Imam¹^ORCID,Esmat Gamal²,Fouad Rabab²,Allam Naglaa¹,Hassany Mohamed³^ORCID,Mohey Mohammad²,Shiha Gamal⁴,Soliman Reham⁴^ORCID,Qaqish Roula B.⁵,Hall Coleen⁵,Alami Negar N.⁵,Kopecky‐Bromberg Sarah⁵,Mobashery Niloufar⁵

Affiliation:

1. National Liver Institute Menoufiya Egypt

2. Cairo University Cairo Egypt

3. National Hepatology and Tropical Medicine Research Institute Cairo Egypt

4. Mansoura University and Egyptian Liver Research Institute and Hospital, (ELRIAH) Mansoura Egypt

5. AbbVie Inc North Chicago Illinois

Funder

AbbVie

Publisher

Wiley

Subject

Infectious Diseases,Virology